Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Clinical Features and the Efficacy of Thrombolytic Therapy in de Winter
Author(s): Nirmalatiban Parthiban , Fiona Boland , Huzairi Sani Added: 8 months ago

Prevention & Chronic Conditions

MI/ACS
TAAD Demographics in the Gulf
Author(s): László Göbölös , Yosef Manla , Naureen Khan , et al Added: 10 months ago

Vascular Disease and Surgery
AHA 25: Lp(a) and ASCVD: Translating Causal Evidence into Clinical Practice
Author(s): Michelle O'Donoghue Added: 1 month ago
AHA Scientific Sessions 2025 - Dr Michelle O'Donoghue (Brigham and Women's Hospital, US) joins us to discuss the evolving understanding of the causal relationship between elevated lipoprotein(a) and atherosclerotic cardiovascular disease, and what this means for risk stratification and management strategies in clinical practice.Dr O'Donoghue begins by highlighting the importance for clinicians to… View more

Cardiovascular Renal Metabolic

Prevention & Chronic Conditions
ADA 25: Clinical Implications of STRIDE for Endocrinologists
Author(s): Added: 5 months ago
ADA 2025 - We are joined by Dr Alice Cheng (University of Toronto, Toronto, CA) to discuss the clinical implications of STRIDE (NCT04560998). The placebo-controlled study investigated whether semaglutide with standard-of-care treatment has an effect on walking ability in patients with PAD and T2D. The primary outcome measure was the change in maximum walking distance on a constant load treadmill… View more

Cardiovascular Renal Metabolic

Vascular Disease and Surgery
Takotsubo Syndrome in a Southeast Asian Population
Author(s): Samuel Soh Heng , Ignasius Jappar , Zee Pin Ding Added: 6 months ago

Heart Failure

Imaging & Diagnostics
Clinical Indications and Outcomes of Adult TOF Reoperation in Japan
Author(s): Atsushi Mizuno , Takayoshi Ueno , Shigeru Tateno , et al Added: 1 year ago

Inherited and Congenital Cardiac Conditions
AHA 23 Late-Breaker Discussion: The ARIES HM3 Clinical Trial
Author(s): Harriette Van Spall , Mandeep Mehra Added: 2 years ago
AHA 23 - Investigator, Dr Mandeep R Mehra (Brigham and Women's Hospital and Harvard Medical School, US) is joined by Late-breaker host, Dr Harriette Van Spall (McMaster University, CA) to discuss the ARIES HM3 trial.ARIES HM3 is a prospective, randomised, double-blinded, placebo-controlled clinical investigation into heart failure (HF) patients treated with the ARIES HeartMate 3 pump, who were… View more

Heart Failure

Electrophysiology & Arrhythmia
AHA 2025: The TIRZSEMA-CVOT Study
Author(s): Nils Krüger Added: 4 weeks ago
AHA Scientific Sessions 2025 - Dr Nils Krüger (Brigham and Women's Hospital, US) joins us to discuss findings from the TIRZSEMA-CVOT (NCT07096063) study, examining real-world cardiovascular outcomes with tirzepatide and semaglutide in patients with type 2 diabetes at cardiovascular risk.This retrospective cohort study utilized three national US claims databases to evaluate over 887,000 patients… View more

Cardiovascular Renal Metabolic

Heart Failure
Drug-coated Balloon Angioplasty in Sri Lanka
Author(s): Yanushka Herath , Judy Ranaweera , Thisal Semina , et al Added: 1 week ago

Intervention

Prevention & Chronic Conditions
ESC 25: The FARADISE Global Registry
Author(s): Lucas Boersma Added: 3 months ago
ESC Congress 2025 - FARADISE Registry finds FARAPULSE™ pulsed field ablation (PFA) system safe and easy to use, with an 80% clinical effectiveness at one year in paroxysmal AF.Prof Lucas Boersma (St Antonius Hospital, Nieuwegein, NL) joins us to discuss one-year findings from the observational, prospective, single-arm FARADISE global registry (NCT05501873) which collected real-world data from up… View more

Electrophysiology & Arrhythmia